ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,525,871 | +5.8% | 723,632 | -5.4% | 0.01% | 0.0% |
| Q3 2022 | $31,683,619 | -20.6% | 765,120 | +14.3% | 0.01% | -20.0% |
| Q2 2022 | $39,928,648 | -17.0% | 669,270 | +1.0% | 0.01% | 0.0% |
| Q1 2022 | $48,123,531 | -7.9% | 662,676 | +6.6% | 0.01% | -9.1% |
| Q4 2021 | $52,268,000 | +3.0% | 621,576 | +10.5% | 0.01% | 0.0% |
| Q3 2021 | $50,735,000 | -12.0% | 562,538 | -6.9% | 0.01% | -8.3% |
| Q2 2021 | $57,624,000 | -7.0% | 604,338 | +11.0% | 0.01% | -14.3% |
| Q1 2021 | $61,991,000 | -20.0% | 544,453 | -2.7% | 0.01% | -22.2% |
| Q4 2020 | $77,444,000 | +98.4% | 559,443 | +17.8% | 0.02% | +80.0% |
| Q3 2020 | $39,026,000 | +5.0% | 474,822 | -0.1% | 0.01% | -9.1% |
| Q2 2020 | $37,182,000 | +63.3% | 475,354 | -7.3% | 0.01% | +37.5% |
| Q1 2020 | $22,773,000 | +4.0% | 512,564 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $21,892,000 | -0.2% | 512,564 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $21,928,000 | -28.7% | 512,564 | +5.8% | 0.01% | -30.0% |
| Q2 2019 | $30,766,000 | +0.7% | 484,506 | +10.0% | 0.01% | 0.0% |
| Q1 2019 | $30,553,000 | +90.4% | 440,507 | +19.4% | 0.01% | +66.7% |
| Q4 2018 | $16,047,000 | -35.4% | 369,078 | +13.4% | 0.01% | -25.0% |
| Q3 2018 | $24,850,000 | -41.9% | 325,514 | -41.5% | 0.01% | -46.7% |
| Q2 2018 | $42,770,000 | -1.6% | 556,394 | -34.7% | 0.02% | -6.2% |
| Q1 2018 | $43,456,000 | +77.3% | 852,253 | +61.2% | 0.02% | +77.8% |
| Q4 2017 | $24,514,000 | -12.9% | 528,530 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $28,150,000 | -14.2% | 528,530 | 0.0% | 0.01% | -15.4% |
| Q2 2017 | $32,827,000 | +7.9% | 528,530 | +17.8% | 0.01% | +8.3% |
| Q1 2017 | $30,414,000 | -17.2% | 448,715 | -14.1% | 0.01% | -25.0% |
| Q4 2016 | $36,717,000 | +3.8% | 522,215 | 0.0% | 0.02% | -5.9% |
| Q3 2016 | $35,383,000 | +147.9% | 522,215 | +79.0% | 0.02% | +142.9% |
| Q2 2016 | $14,271,000 | -26.5% | 291,789 | -4.8% | 0.01% | -30.0% |
| Q1 2016 | $19,410,000 | -43.6% | 306,589 | 0.0% | 0.01% | -41.2% |
| Q4 2015 | $34,393,000 | +21.0% | 306,589 | +3.9% | 0.02% | +13.3% |
| Q3 2015 | $28,433,000 | +13.0% | 295,222 | +20.2% | 0.02% | +15.4% |
| Q2 2015 | $25,152,000 | +1741.3% | 245,645 | +1016.6% | 0.01% | +1200.0% |
| Q1 2015 | $1,366,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |